NCT04671875 2024-03-13
A Clinical Study of MIL93 in Solid Tumors.
Beijing Mabworks Biotech Co., Ltd.
Phase 1 Unknown
Clinical Trials
6 trialsNCT04916119 2022-09-16
Study of IBI323 in Patients With Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Unknown
NCT04085185 2022-09-14
A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Unknown
NCT05024305 2022-03-09
Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies.
Shandong TheraWisdom Biopharma Co., Ltd.
Phase 1 Unknown
NCT04340427 2020-07-01
A Study of TQB3455 Tablets in Subjects With Advanced Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT01079702 2010-03-03
m-TOR
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1/2 Unknown